Celardo Ivana, Aschner Michael, Ashton Randolph S, Carstens Kelly E, Cediel-Ulloa Andrea, Cöllen Eike, Crofton Kevin M, Debad Susan J, Dreser Nadine, Fitzpatrick Suzanne, Fritsche Ellen, Gutsfeld Sebastian, Hardy Barry, Hartung Thomas, Hessel Ellen, Heusinkveld Harm, Hogberg Helena T, Hsieh Jui-Hua, Kanda Yasunari, Knight Gavin T, Knudsen Thomas, Koch Katharina, Kuchovska Eliska, Mangas Iris, Marty M Sue, Melching-Kollmuss Stephanie, Müller Iris, Müller Patrick, Myhre Oddvar, Paparella Martin, Pitzer Emily, Bal-Price Anna, Sachana Magdalini, Schlüppmann Kevin, Shafer Timothy J, Schäfer Jasmin, Smirnova Lena, Tal Tamara, Tanaskov Yaroslav, Tangianu Silvia, Testa Giuseppe, Ückert Anna-Katharina, Whelan Maurice, Leist Marcel
In vitro Toxicology and Biomedicine, University of Konstanz, Konstanz, Germany.
CAAT-Europe, University of Konstanz, Konstanz, Germany.
ALTEX. 2025;42(2):323-349. doi: 10.14573/altex.2503191.
The 5th International Conference on Developmental Neurotoxicity (DNT) Testing (DNT5) took place in April 2024 in Konstanz, Germany, organized by CAAT-Europe, the University of Konstanz, and scientists from the US EPA, SCAHT, and CAAT at Johns Hopkins University Bloomberg School of Public Health. The conference convened experts from regulatory agencies, industry, and academia to explore the latest advancements in DNT testing and the integration of animal-free new approach methodologies (NAMs) into next-generation risk assessment (NGRA). The key topic was the appli-cation and further development of the recently established DNT in vitro test battery (DNT-IVB). To support this, OECD held a satellite meeting to discuss necessary next steps for further implementation of the DNT-IVB in regulatory contexts. Validation of new DNT test methods and use of their data for in-vitro-to-in-vivo extrapolations in physiologically based kinetic models were also important themes of the main meeting. In this context, the question was raised when a comprehensive biological and chemical coverage by the DNT-IVB would be reached. A need for additional testing data was recognized. Context-specific validation approaches for the entire DNT-IVB and the potential for intelligent combinations of assays to enhance the predictive power of the test battery were also addressed. Many presentations demonstrated the field's embrace of novel developments, including the use of multi-endpoint embryonic zebrafish tests, the development of artificial intelligence-driven computational approaches, and the establishment of complex, electrically active brain organoids and other self-organizing structures. Through its highly interactive format, DNT5 promoted extensive collaborative efforts in advancing the field toward more human-relevant, scientifically reliable, and ethical toxicological assessments.
第五届发育神经毒性(DNT)测试国际会议(DNT5)于2024年4月在德国康斯坦茨举行,由欧洲替代方法验证中心(CAAT-Europe)、康斯坦茨大学以及美国环境保护局(US EPA)、SCAHT和约翰·霍普金斯大学布隆伯格公共卫生学院的CAAT科学家共同组织。会议召集了来自监管机构、行业和学术界的专家,探讨DNT测试的最新进展以及将无动物新方法学(NAMs)整合到下一代风险评估(NGRA)中。关键主题是最近建立的DNT体外测试组合(DNT-IVB)的应用和进一步发展。为此,经济合作与发展组织(OECD)召开了一次卫星会议,讨论在监管环境中进一步实施DNT-IVB所需的后续步骤。新DNT测试方法的验证以及将其数据用于基于生理动力学模型的体外到体内外推也是主要会议的重要主题。在这种背景下,有人提出DNT-IVB何时能实现全面的生物和化学覆盖的问题。人们认识到需要更多的测试数据。还讨论了针对整个DNT-IVB的特定背景验证方法以及检测方法智能组合以提高测试组合预测能力的可能性。许多报告展示了该领域对新进展的接受,包括使用多终点胚胎斑马鱼测试、人工智能驱动的计算方法的开发以及复杂的、电活性脑类器官和其他自组织结构的建立。通过其高度互动的形式,DNT5促进了广泛的合作努力,推动该领域朝着更符合人类实际情况、科学可靠且符合伦理的毒理学评估发展。